Investigational Drug Information for HSK3486
✉ Email this page to a colleague
What is the development status for investigational drug HSK3486?
HSK3486 is an investigational drug.
There have been 30 clinical trials for HSK3486.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 9th 2018.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Liver Neoplasms. The leading clinical trial sponsors are Sichuan Haisco Pharmaceutical Group Co., Ltd., Sichuan Haisco Pharmaceutical Group Co., Ltd, and Haisco-USA Pharmaceuticals, Inc.
There are two US patents protecting this investigational drug and thirty-seven international patents.
Summary for HSK3486
| US Patents | 2 |
| International Patents | 37 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2018-10-09) |
| Vendors | 17 |
Recent Clinical Trials for HSK3486
| Title | Sponsor | Phase |
|---|---|---|
| Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation | Zhejiang Cancer Hospital | N/A |
| Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of Recovery | Xijing Hospital | N/A |
| Safety and Efficacy of HSK3486 Compares to Propofol for Induction of General Anesthesia in Adults With Elective Surgery | Haisco-USA Pharmaceuticals, Inc. | Phase 3 |
Clinical Trial Summary for HSK3486
Top disease conditions for HSK3486
Top clinical trial sponsors for HSK3486
US Patents for HSK3486
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| HSK3486 | ⤷ Subscribe | Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament | HAISCO CHENGDU PHARMACEUTICAL TECHNOLOGY CO., LTD. (Chengdu, Sichuan, CN) | ⤷ Subscribe |
| HSK3486 | ⤷ Subscribe | Phenol derivative and preparation method and use in medicine thereof | Sichuan Haisco Pharmaceutical Co., Ltd. (Chengdu, CN) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for HSK3486
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| HSK3486 | Australia | AU2015311394 | 2034-09-04 | ⤷ Subscribe |
| HSK3486 | Brazil | BR112017004448 | 2034-09-04 | ⤷ Subscribe |
| HSK3486 | Canada | CA2959812 | 2034-09-04 | ⤷ Subscribe |
| HSK3486 | China | CN105579034 | 2034-09-04 | ⤷ Subscribe |
| HSK3486 | Eurasian Patent Organization | EA035649 | 2034-09-04 | ⤷ Subscribe |
| HSK3486 | Eurasian Patent Organization | EA201790525 | 2034-09-04 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
